CHAM
PFE icon

Clear Harbor Asset Management’s Pfizer PFE Stock Holding History

Clear Harbor Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,000
Closed -$145K – 415
2024
Q3 		$145K Buy
+5,000
New +$146K 0.01% 348

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Clear Harbor Asset Management's PFE Position: Q1 2026 in Review

Clear Harbor Asset Management increased its Pfizer (PFE) stake by 23% in Q1 2026, buying an estimated $721K and bringing the position to 146,263 shares worth $4.11M. The position accounts for 0.28% of the portfolio, ranked #77.

Clear Harbor Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.92M in Q1 2015. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Clear Harbor Asset Management held 146,263 shares of Pfizer worth $4.11M as of Q1 2026.
  • Clear Harbor Asset Management bought 27,096 Pfizer shares in Q1 2026, an estimated $721K.
  • Pfizer made up 0.28% of Clear Harbor Asset Management's portfolio in Q1 2026, its #77 holding.
  • Clear Harbor Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Clear Harbor Asset Management's Pfizer position peaked at $4.92M in Q1 2015.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Clear Harbor Asset Management's 13F filing for Q1 2026, filed 5 May 2026.